Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3520 ARTÍCULOS , VIENDO DEL 1771 AL 1785

Age and sex variation in prevalence of chronic medical conditions in older residents of U.S. nursing homes

Moore KL, Boscardin WJ, Steinman MA, Schwartz JB.

J Am Geriatr Soc. 2012 Apr;60(4):756-64. doi: 10.1111/j.1532-5415.2012.03909.x. Epub 2012 Mar 29.

Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS

Tassone F, Greco CM, Hunsaker MR, Seritan AL, Berman RF, Gane LW, Jacquemont S, Basuta K, Jin LW, Hagerman PJ, Hagerman RJ.

Genes Brain Behav. 2012 Jul;11(5):577-85. doi: 10.1111/j.1601-183X.2012.00779.x. Epub 2012 Apr 6.

Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Allen PJ.

Neurosci Biobehav Rev. 2012 May;36(5):1442-62. doi: 10.1016/j.neubiorev.2012.03.005. Epub 2012 Mar 24.

Challenges in multi-plex and mono-plex platforms for the discovery of inflammatory profiles in neurodegenerative diseases

Malekzadeh A, de Groot V, Beckerman H, van Oosten BW, Blankenstein MA, Teunissen C.

Methods. 2012 Apr;56(4):508-13. doi: 10.1016/j.ymeth.2012.03.017. Epub 2012 Mar 24.

The effect of levodopa on pulmonary function in Parkinson's disease: a systematic review and meta-analysis

Monteiro L, Souza-Machado A, Valderramas S, Melo A.

Clin Ther. 2012 May;34(5):1049-55. doi: 10.1016/j.clinthera.2012.03.001. Epub 2012 Mar 31.

Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid

Kruse N, Schulz-Schaeffer WJ, Schlossmacher MG, Mollenhauer B.

Methods. 2012 Apr;56(4):514-8. doi: 10.1016/j.ymeth.2012.03.016. Epub 2012 Mar 23.

Drug safety evaluation of rotigotine

Sprenger FS, Seppi K, Poewe W.

Expert Opin Drug Saf. 2012 May;11(3):503-12. doi: 10.1517/14740338.2012.678830. Epub 2012 Apr 3.

Gene expression profiling and therapeutic interventions in neurodegenerative diseases: a comprehensive study on potentiality and limits

Benetti F, Gustincich S, Legname G.

Expert Opin Drug Discov. 2012 Mar;7(3):245-59. doi: 10.1517/17460441.2012.659661. Epub 2012 Feb 13.

Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders

Célanire S, Campo B.

Expert Opin Drug Discov. 2012 Mar;7(3):261-80. doi: 10.1517/17460441.2012.660914. Epub 2012 Feb 14.

Accuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers

Feldman AL, Johansson AL, Gatz M, Flensburg M, Petzinger GM, Widner H, Lew MF, Pedersen NL, Wirdefeldt K.

Neuroepidemiology. 2012;38(3):186-93. doi: 10.1159/000336356. Epub 2012 Mar 29.

Sleep-wake disturbances in Parkinson's disease: current evidence regarding diagnostic and therapeutic decisions

Bruin VM, Bittencourt LR, Tufik S.

Eur Neurol. 2012;67(5):257-67. doi: 10.1159/000335078. Epub 2012 Mar 30.

Amantadine: the journey from fighting flu to treating Parkinson disease

Hubsher G, Haider M, Okun MS.

Neurology. 2012 Apr 3;78(14):1096-9. doi: 10.1212/WNL.0b013e31824e8f0d.

The role of autophagy in Parkinson's disease

Lynch-Day MA, Mao K, Wang K, Zhao M, Klionsky DJ.

Cold Spring Harb Perspect Med. 2012 Apr;2(4):a009357. doi: 10.1101/cshperspect.a009357.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias